Cargando…
Is Slovakia Almost a Hepatitis D Free Country?
Background: It is assumed that the prevalence of hepatitis D in HBsAg-positive individuals reaches 4.5–13% in the world and on average about 3% in Europe. Data from several European countries, including Slovakia, are missing or are from an older period. Methods: We analyzed all available data on hep...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459979/ https://www.ncbi.nlm.nih.gov/pubmed/37632037 http://dx.doi.org/10.3390/v15081695 |
_version_ | 1785097541628461056 |
---|---|
author | Kristian, Pavol Hockicková, Ivana Hatalová, Elena Žilinčanová, Daniela Rác, Marek Bednárová, Veronika Lenártová, Patrícia Denisa Dražilová, Sylvia Skladaný, Ľubomír Schréter, Ivan Jarčuška, Peter Halánová, Monika |
author_facet | Kristian, Pavol Hockicková, Ivana Hatalová, Elena Žilinčanová, Daniela Rác, Marek Bednárová, Veronika Lenártová, Patrícia Denisa Dražilová, Sylvia Skladaný, Ľubomír Schréter, Ivan Jarčuška, Peter Halánová, Monika |
author_sort | Kristian, Pavol |
collection | PubMed |
description | Background: It is assumed that the prevalence of hepatitis D in HBsAg-positive individuals reaches 4.5–13% in the world and on average about 3% in Europe. Data from several European countries, including Slovakia, are missing or are from an older period. Methods: We analyzed all available data on hepatitis D from Slovakia, including reports from the Slovak Public Health Authority and the results of one prospective study, and three smaller surveys. The determination of anti-HDV IgG and IgM antibodies and/or HDV RNA was used to detect hepatitis D. Results: In the years 2005–2022, no confirmed case of acute or chronic HDV infection was reported in Slovakia. The presented survey includes a total of 343 patients, of which 126 were asymptomatic HBsAg carriers, 33 acute hepatitis B, and 184 chronic hepatitis B cases. In a recent prospective study of 206 HBsAg-positive patients who were completely serologically and virologically examined for hepatitis B and D, only 1 anti-HDV IgG-positive and no anti-HDV IgM or HDV RNA-positive cases were detected. In other smaller surveys, two anti-HDV IgG-positive patients were found without the possibility of HDV RNA confirmation. In total, only 3 of 329 HBsAg-positive patients (0.91%) tested positive for anti-HDV IgG antibodies, and none of 220 tested positive for HDV RNA. Conclusion: The available data show that Slovakia is one of the countries with a very low prevalence of HDV infection, reaching less than 1% in HBsAg-positive patients. Routine testing for hepatitis D is lacking in Slovakia, and therefore it is necessary to implement testing of all HBsAg-positive individuals according to international recommendations. |
format | Online Article Text |
id | pubmed-10459979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104599792023-08-27 Is Slovakia Almost a Hepatitis D Free Country? Kristian, Pavol Hockicková, Ivana Hatalová, Elena Žilinčanová, Daniela Rác, Marek Bednárová, Veronika Lenártová, Patrícia Denisa Dražilová, Sylvia Skladaný, Ľubomír Schréter, Ivan Jarčuška, Peter Halánová, Monika Viruses Article Background: It is assumed that the prevalence of hepatitis D in HBsAg-positive individuals reaches 4.5–13% in the world and on average about 3% in Europe. Data from several European countries, including Slovakia, are missing or are from an older period. Methods: We analyzed all available data on hepatitis D from Slovakia, including reports from the Slovak Public Health Authority and the results of one prospective study, and three smaller surveys. The determination of anti-HDV IgG and IgM antibodies and/or HDV RNA was used to detect hepatitis D. Results: In the years 2005–2022, no confirmed case of acute or chronic HDV infection was reported in Slovakia. The presented survey includes a total of 343 patients, of which 126 were asymptomatic HBsAg carriers, 33 acute hepatitis B, and 184 chronic hepatitis B cases. In a recent prospective study of 206 HBsAg-positive patients who were completely serologically and virologically examined for hepatitis B and D, only 1 anti-HDV IgG-positive and no anti-HDV IgM or HDV RNA-positive cases were detected. In other smaller surveys, two anti-HDV IgG-positive patients were found without the possibility of HDV RNA confirmation. In total, only 3 of 329 HBsAg-positive patients (0.91%) tested positive for anti-HDV IgG antibodies, and none of 220 tested positive for HDV RNA. Conclusion: The available data show that Slovakia is one of the countries with a very low prevalence of HDV infection, reaching less than 1% in HBsAg-positive patients. Routine testing for hepatitis D is lacking in Slovakia, and therefore it is necessary to implement testing of all HBsAg-positive individuals according to international recommendations. MDPI 2023-08-05 /pmc/articles/PMC10459979/ /pubmed/37632037 http://dx.doi.org/10.3390/v15081695 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kristian, Pavol Hockicková, Ivana Hatalová, Elena Žilinčanová, Daniela Rác, Marek Bednárová, Veronika Lenártová, Patrícia Denisa Dražilová, Sylvia Skladaný, Ľubomír Schréter, Ivan Jarčuška, Peter Halánová, Monika Is Slovakia Almost a Hepatitis D Free Country? |
title | Is Slovakia Almost a Hepatitis D Free Country? |
title_full | Is Slovakia Almost a Hepatitis D Free Country? |
title_fullStr | Is Slovakia Almost a Hepatitis D Free Country? |
title_full_unstemmed | Is Slovakia Almost a Hepatitis D Free Country? |
title_short | Is Slovakia Almost a Hepatitis D Free Country? |
title_sort | is slovakia almost a hepatitis d free country? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459979/ https://www.ncbi.nlm.nih.gov/pubmed/37632037 http://dx.doi.org/10.3390/v15081695 |
work_keys_str_mv | AT kristianpavol isslovakiaalmostahepatitisdfreecountry AT hockickovaivana isslovakiaalmostahepatitisdfreecountry AT hatalovaelena isslovakiaalmostahepatitisdfreecountry AT zilincanovadaniela isslovakiaalmostahepatitisdfreecountry AT racmarek isslovakiaalmostahepatitisdfreecountry AT bednarovaveronika isslovakiaalmostahepatitisdfreecountry AT lenartovapatriciadenisa isslovakiaalmostahepatitisdfreecountry AT drazilovasylvia isslovakiaalmostahepatitisdfreecountry AT skladanylubomir isslovakiaalmostahepatitisdfreecountry AT schreterivan isslovakiaalmostahepatitisdfreecountry AT jarcuskapeter isslovakiaalmostahepatitisdfreecountry AT halanovamonika isslovakiaalmostahepatitisdfreecountry |